Related Experiment Video
Updated: Jul 6, 2025
07:18
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
5.8K
Targeting noncoding RNAs to reactivate or eliminate latent HIV reservoirs
1Department of Medicine, University of California at San Diego.
Current Opinion in HIV and AIDS
|January 3, 2024
Summary
Noncoding RNAs (ncRNAs) show specific expression patterns, offering potential targets for HIV eradication. Further research is needed to fully understand ncRNA roles in HIV latency and reactivation for effective therapies.
Area of Science:
- Molecular Biology
- Virology
- Immunology
Background:
- Noncoding RNAs (ncRNAs) exhibit distinct tissue and cell type-specific expression, differing from protein-coding genes.
- Understanding ncRNA roles in HIV replication and latency is crucial for developing targeted therapies against the latent HIV reservoir.
- ncRNAs are implicated in complex interactions with other RNAs and proteins, influencing HIV dynamics.
Approach:
- Investigating ncRNA mechanisms of action and their impact on HIV replication and latency.
- Evaluating the efficacy of latency-reversing agents on ncRNA expression and HIV reactivation.
- Addressing the limitations of cell line-based research by exploring ncRNA function in primary cells.
Key Points:
- ncRNA expression is highly specific, potentially enabling targeted HIV therapies.
- Latency-reversing agents can modulate ncRNA expression, with some inhibiting HIV reactivation.
- Current research limitations include reliance on cell lines, necessitating studies in primary cells due to cell type specificity.
Conclusions:
- Comprehensive screens are required to identify all ncRNAs regulating HIV and their mechanisms for reservoir clearance.
- Targeting classes of ncRNAs may offer a more effective strategy for HIV reservoir elimination than individual ncRNAs.
- Future compound screens for latency reversal must account for the intricate effects on ncRNA networks.
